The email looks ordinary. Same product, it says, same manufacturer, better price, shipped direct. You have been waiting three weeks on an account application with one of the handful of authorised distributors, your schedule is full, and the offer solves this week's problem.
That is how most providers who end up outside the legitimate supply chain get there. Not through greed — through impatience and a plausible email.
How Counterfeit Botox Reaches a Practice
Michelle Langston APRN describes the route precisely, and she is careful about who it catches.
“Some people don't understand — you step out into aesthetics and they don't really know that they can't order from a third party,” she says. “So they're unwittingly in their email, they get: hey, you can get these products that are approved sent right to you. Because they might be waiting and trying to get products from one of the big five or six businesses, and they're not able to do that right away. They've been told these are approved, and they go ahead and order them, and they don't know.”
Her phrase for this is the unsuspecting injector, and it is the honest description. The counterfeit market does not advertise itself as counterfeit. It advertises itself as the same thing, sooner.
Dr. Chris Croley, Empire's Chief Medical Officer, confirms how routine the approach is: “We get solicitation from companies to say, here, you can buy this product, it's legal, it's coming from the same place. They all tell you that.”
What Is Actually in the Syringe
The clinical problem is not that the product is cheaper. It is that nothing about it is known.
Langston lists what is being risked: “Illness, disfigurement, infection — things being injected when we don't know really how they were prepared, where they were prepared, or even what's in the syringe that they're injecting.”
Read that as three separate unknowns, because they are:
- Identity — whether the active agent is what the carton claims, at the stated concentration, or at any consistent concentration between vials.
- Sterility and preparation — where it was compounded or filled, under what conditions, and whether it has been temperature-controlled since.
- Provenance — whether a product approved somewhere else is being presented as approved here, which is a different claim entirely.
A vial that fails on any one of those is not a cheaper version of the real thing. It is an unknown injected into a face.
Buying Botox Online Is Not a Shortcut
The legitimate route is deliberately slow. Opening an account with an authorised distributor means proving licensure, prescriptive authority, a practice address and a medical director where the state requires one. As Croley puts it, it is “quite challenging for providers to really open accounts, to prove all the necessary things that we need to show documentation of to actually get legitimate products.”
That friction is the control. It is the mechanism that keeps prescription-only injectables in the hands of people who may lawfully order and administer them — which is also the substance of who can administer Botox.
An offer that removes the friction has removed the control. There is no third version where the paperwork is skipped and the product is still verified.
Three Kinds of Consequence, Not One
This is the part Croley says providers consistently get wrong, and it is worth stating plainly.
“If there's a bad outcome, there could be civil charges or civil complaints from the patient where they sue you,” he says. “There could be criminal complaints or criminal charges, depending on the degree of damage, and in some places that could require even jail time. But more than all of that, there can be regulatory things against our license. I think we forget that there's three different categories that can be affected. We only think about the patient suing us.”
Then the sentence that should end the argument: “Oftentimes I'll say, well, I did a consent, I told them this. And I'm like — well, that consent doesn't protect you from the medical board or the nursing board when they find out that you did something like that, and you can put your license at risk.”
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
A consent form documents that a patient accepted the risks of a procedure. It says nothing about where the product came from, and it is not a defence before a licensing board. The relevant consent conversation — including the second consent for hyaluronidase — is covered in hyaluronidase consent and the good faith exam.
Approved Product Used the Wrong Way
There is a quieter version of the same problem, and Langston flags it as something she sees often: a legitimately sourced product administered by a route it was never approved for.
“Using even approved medications not in the way that they are approved to be used on patients,” she says — her example being substances cleared for topical or microneedling use that get injected instead.
The vial is real. The supply chain is clean. The route is not the one the approval covers, which puts the provider back in the same regulatory position. Sourcing is one question and administration is another, and passing the first does not answer the second. The same distinction governs the exosome category, where topical and injected are genuinely different regulatory questions — see are exosomes FDA approved.
What a Legitimate Supply Chain Looks Like
The checks are unglamorous and they take a few minutes:
- Order only from an authorised distributor or the manufacturer, through an account held in the practice's name.
- Match the account to the authority. Whoever holds the account must hold the prescriptive authority that the product requires.
- Check the carton and lot against the order on arrival, and keep the record.
- Confirm the cold chain for anything that requires it, and reject shipments that arrive warm.
- Treat unsolicited offers as a category, not case by case. If the approach arrives by email and bypasses credentialing, the answer is already no.
- Verify the route the product is approved for before the first use, not the first complication.
Croley's position on where this belongs is straightforward: “We go above and beyond to try to educate on that, and partner with companies that have approved products through approved distribution chains.”
What to Tell Patients Who Ask
Patients are now asking, and Langston treats that as an opportunity rather than an awkwardness. “This is such a hot topic for us right now, and I think it's impacting our practices probably more than I've ever seen. Patients are going to come in and they're going to start questioning us about this, and I welcome that. I'm more than happy to answer those questions.”
Which is the commercially useful point. A practice that can say where its product comes from, show the account, and explain why it will not take a shortcut has a sales advantage over one that treats the question as an insult. It is the same posture that makes a practice recognisably medical rather than cosmetic — the argument in what is a med spa.
Tatiana Sarmiento NP applies the same test to the wider problem of non-medical injectors advertising on social media: “You have to be responsible for the action that you take, and then what you show to the public.”
Empire teaches product handling, reconstitution and the regulatory frame alongside technique in Complete Botox Training, and the practice-side compliance questions across the business and marketing academy.
Frequently Asked Questions
What is counterfeit Botox?
Product sold as a branded neurotoxin that did not come through the manufacturer's authorised distribution chain. It may be mislabelled, differently concentrated, non-sterile, approved only in another country, or something else entirely. The defining problem is that its identity, preparation and storage history are all unverifiable.
Why can't a practice buy injectables online?
Prescription-only injectables are supplied through authorised distributors who verify licensure, prescriptive authority and practice details before opening an account. An offer that skips that verification has skipped the only mechanism that confirms what is in the vial.
Does a signed consent form protect a provider who used an unapproved product?
No. Faculty are explicit on this: a consent documents that the patient accepted procedural risk. It is not a defence before a medical or nursing board, and it does not address sourcing at all. Three categories of exposure exist — civil, criminal and regulatory — and consent speaks to none of them.
Is a legitimately purchased product always safe to inject?
Not automatically. Faculty describe seeing approved products administered by routes they were never approved for — agents cleared for topical or microneedling use being injected instead. Correct sourcing and correct administration are separate obligations.
Disclaimer
This article is educational and intended for licensed clinicians. It is not legal or medical advice and does not establish a clinician-patient relationship. Regulatory requirements, scope of practice and distribution rules vary by state and change over time; verify the current position with your own licensing board and counsel, and practise within your scope and applicable law.
Claim Your Prize!